Trulicity (dulaglutide) is a glucagon-like peptide-1 (GLP-1) agonist that helps control blood sugar in people 10 years and older with Type 2 diabetes. It's also approved to lower the risk of heart problems like heart attacks, strokes, and heart-related death in certain adults with Type 2 diabetes. The medication is injected under the skin once a week. Common side effects include nausea, vomiting, diarrhea, and stomach pain. When taken with certain diabetes medications like insulin, there's a higher risk of low blood sugar (hypoglycemia).
Indications of Mounjaro vs. Trulicity
Indications for
•Type 2 diabetes in adults and children 10 years of age and older
Indications for
•Manage Type 2 diabetes in people 10 years and older, along with diet and exercise
•Lower the risk of heart problems like heart attack, stroke, or death in adults with Type 2 diabetes who have heart disease or heart-related risk factors
Pros and Cons of Mounjaro vs. Trulicity
Pros and Const for GIP and GLP-1 agonist
Pros
•Given once weekly
•Can lower A1C by an average of up to 2.3% in about 9 months